Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

Breast Cancer Res · 2025 · PMC12257726 · PMID 40660361

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

IF staining revealed that MΦs (PR) expressed lower levels of CD86 and showed a trend of CD163 upregulation, which resulted in the increased CD163/CD86 ratio compared to MΦs (PS) (Fig. 4 F-H).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.